Global Anti-infective API Market Research Report 2023

Publication ID:

PB503236052

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Anti-infective API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anti-infective API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-infective API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anti-infective API include North China Pharmaceutical, CSPC, Harbin Pharmaceutical Group Pharmaceutical General Factory, Henan Huaxing Pharmaceutical Factory, Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical, Zhangjiakou Diha Pharmaceutical, Shandong Lukang Medicine, Zhuhai United Laboratories and Lunan Pharmaceutical Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-infective API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infective API.
The Anti-infective API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-infective API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-infective API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
Segment by Type
尾-lactam Drugs
Macrolides
Carbapenems
Quinolones
Segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-infective API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Anti-infective API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Anti-infective API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Anti-infective API Market Overview
1.1 Product Definition
1.2 Anti-infective API Segment by Type
1.2.1 Global Anti-infective API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 尾-lactam Drugs
1.2.3 Macrolides
1.2.4 Carbapenems
1.2.5 Quinolones
1.3 Anti-infective API Segment by Application
1.3.1 Global Anti-infective API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Antibacterial Drugs for Systemic Use
1.3.3 Antiviral Drugs for Systemic Use
1.3.4 Antigen for Whole Body
1.3.5 Bacteria
1.3.6 Immune Serum and Immunoglobulin
1.3.7 Anti-mycobacterial Drugs
1.3.8 Vaccine
1.3.9 Other
1.4 Global Market Growth Prospects
1.4.1 Global Anti-infective API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Anti-infective API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Anti-infective API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Anti-infective API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Anti-infective API Production Market Share by Manufacturers (2018-2023)
2.2 Global Anti-infective API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Anti-infective API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Anti-infective API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Anti-infective API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Anti-infective API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Anti-infective API, Product Offered and Application
2.8 Global Key Manufacturers of Anti-infective API, Date of Enter into This Industry
2.9 Anti-infective API Market Competitive Situation and Trends
2.9.1 Anti-infective API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Anti-infective API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Anti-infective API Production by Region
3.1 Global Anti-infective API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-infective API Production Value by Region (2018-2029)
3.2.1 Global Anti-infective API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Anti-infective API by Region (2024-2029)
3.3 Global Anti-infective API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Anti-infective API Production by Region (2018-2029)
3.4.1 Global Anti-infective API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Anti-infective API by Region (2024-2029)
3.5 Global Anti-infective API Market Price Analysis by Region (2018-2023)
3.6 Global Anti-infective API Production and Value, Year-over-Year Growth
3.6.1 North America Anti-infective API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Anti-infective API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Anti-infective API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Anti-infective API Production Value Estimates and Forecasts (2018-2029)
4 Anti-infective API Consumption by Region
4.1 Global Anti-infective API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Anti-infective API Consumption by Region (2018-2029)
4.2.1 Global Anti-infective API Consumption by Region (2018-2023)
4.2.2 Global Anti-infective API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Anti-infective API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Anti-infective API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Anti-infective API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Anti-infective API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Anti-infective API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Anti-infective API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Anti-infective API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Anti-infective API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Anti-infective API Production by Type (2018-2029)
5.1.1 Global Anti-infective API Production by Type (2018-2023)
5.1.2 Global Anti-infective API Production by Type (2024-2029)
5.1.3 Global Anti-infective API Production Market Share by Type (2018-2029)
5.2 Global Anti-infective API Production Value by Type (2018-2029)
5.2.1 Global Anti-infective API Production Value by Type (2018-2023)
5.2.2 Global Anti-infective API Production Value by Type (2024-2029)
5.2.3 Global Anti-infective API Production Value Market Share by Type (2018-2029)
5.3 Global Anti-infective API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Anti-infective API Production by Application (2018-2029)
6.1.1 Global Anti-infective API Production by Application (2018-2023)
6.1.2 Global Anti-infective API Production by Application (2024-2029)
6.1.3 Global Anti-infective API Production Market Share by Application (2018-2029)
6.2 Global Anti-infective API Production Value by Application (2018-2029)
6.2.1 Global Anti-infective API Production Value by Application (2018-2023)
6.2.2 Global Anti-infective API Production Value by Application (2024-2029)
6.2.3 Global Anti-infective API Production Value Market Share by Application (2018-2029)
6.3 Global Anti-infective API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 North China Pharmaceutical
7.1.1 North China Pharmaceutical Anti-infective API Corporation Information
7.1.2 North China Pharmaceutical Anti-infective API Product Portfolio
7.1.3 North China Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 North China Pharmaceutical Main Business and Markets Served
7.1.5 North China Pharmaceutical Recent Developments/Updates
7.2 CSPC
7.2.1 CSPC Anti-infective API Corporation Information
7.2.2 CSPC Anti-infective API Product Portfolio
7.2.3 CSPC Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 CSPC Main Business and Markets Served
7.2.5 CSPC Recent Developments/Updates
7.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
7.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Corporation Information
7.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Portfolio
7.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business and Markets Served
7.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
7.4 Henan Huaxing Pharmaceutical Factory
7.4.1 Henan Huaxing Pharmaceutical Factory Anti-infective API Corporation Information
7.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Portfolio
7.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Henan Huaxing Pharmaceutical Factory Main Business and Markets Served
7.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
7.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
7.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Corporation Information
7.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Portfolio
7.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business and Markets Served
7.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
7.6 Zhangjiakou Diha Pharmaceutical
7.6.1 Zhangjiakou Diha Pharmaceutical Anti-infective API Corporation Information
7.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Portfolio
7.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Zhangjiakou Diha Pharmaceutical Main Business and Markets Served
7.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
7.7 Shandong Lukang Medicine
7.7.1 Shandong Lukang Medicine Anti-infective API Corporation Information
7.7.2 Shandong Lukang Medicine Anti-infective API Product Portfolio
7.7.3 Shandong Lukang Medicine Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Shandong Lukang Medicine Main Business and Markets Served
7.7.5 Shandong Lukang Medicine Recent Developments/Updates
7.8 Zhuhai United Laboratories
7.8.1 Zhuhai United Laboratories Anti-infective API Corporation Information
7.8.2 Zhuhai United Laboratories Anti-infective API Product Portfolio
7.8.3 Zhuhai United Laboratories Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Zhuhai United Laboratories Main Business and Markets Served
7.7.5 Zhuhai United Laboratories Recent Developments/Updates
7.9 Lunan Pharmaceutical Group
7.9.1 Lunan Pharmaceutical Group Anti-infective API Corporation Information
7.9.2 Lunan Pharmaceutical Group Anti-infective API Product Portfolio
7.9.3 Lunan Pharmaceutical Group Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Lunan Pharmaceutical Group Main Business and Markets Served
7.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
7.10 Sandoz
7.10.1 Sandoz Anti-infective API Corporation Information
7.10.2 Sandoz Anti-infective API Product Portfolio
7.10.3 Sandoz Anti-infective API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Sandoz Main Business and Markets Served
7.10.5 Sandoz Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Anti-infective API Industry Chain Analysis
8.2 Anti-infective API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Anti-infective API Production Mode & Process
8.4 Anti-infective API Sales and Marketing
8.4.1 Anti-infective API Sales Channels
8.4.2 Anti-infective API Distributors
8.5 Anti-infective API Customers
9 Anti-infective API Market Dynamics
9.1 Anti-infective API Industry Trends
9.2 Anti-infective API Market Drivers
9.3 Anti-infective API Market Challenges
9.4 Anti-infective API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂